Year |
Citation |
Score |
2017 |
Yeung CL, Tsang TY, Yau PL, Kwok TT. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3. Oncotarget. PMID 28077801 DOI: 10.18632/Oncotarget.14555 |
0.729 |
|
2012 |
Sun J, Yeung CA, Co NN, Tsang TY, Yau E, Luo K, Wu P, Wa JC, Fung KP, Kwok TT, Liu F. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line. Plos One. 7: e40720. PMID 22927901 DOI: 10.1371/Journal.Pone.0040720 |
0.69 |
|
2011 |
Sun JG, Chen CY, Luo KW, Yeung CL, Tsang TY, Huang ZZ, Wu P, Fung KP, Kwok TT, Liu FY. 3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells. Chemotherapy. 57: 162-72. PMID 21454974 DOI: 10.1159/000326915 |
0.665 |
|
2011 |
Tsang TY, Tang WY, Chan JY, Co NN, Au Yeung CL, Yau PL, Kong SK, Fung KP, Kwok TT. P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells. Apoptosis : An International Journal On Programmed Cell Death. 16: 524-35. PMID 21336967 DOI: 10.1007/S10495-011-0581-5 |
0.7 |
|
2011 |
Au Yeung CL, Tsang TY, Yau PL, Kwok TT. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene. 30: 2401-10. PMID 21242962 DOI: 10.1038/onc.2010.613 |
0.721 |
|
2011 |
Yeung CLA, Tsang TY, Yau PL, Kwok TT. Abstract 3960: MicroRNA-23b targeting urokinase-type plasminogen activator facilitates human papillomavirus type 16 E6 induction of cervical cancer cell migration Cancer Research. 71: 3960-3960. DOI: 10.1158/1538-7445.Am2011-3960 |
0.573 |
|
2011 |
Tsang TY, Yeung CLA, Yau PL, Kwok TT. Abstract 1702: S-adenosyl-L-methionine induces P-glycoprotein overexpression and drug resistance in human cancer cells Cancer Research. 71: 1702-1702. DOI: 10.1158/1538-7445.Am2011-1702 |
0.501 |
|
2010 |
Au Yeung CL, Tsang WP, Tsang TY, Co NN, Yau PL, Kwok TT. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncology Reports. 24: 1599-604. PMID 21042757 DOI: 10.3892/Or_00001023 |
0.701 |
|
2010 |
Co NN, Tsang WP, Tsang TY, Yeung CL, Yau PL, Kong SK, Kwok TT. AF1q enhancement of gamma irradiation-induced apoptosis by up-regulation of BAD expression via NF-kappaB in human squamous carcinoma A431 cells. Oncology Reports. 24: 547-54. PMID 20596645 DOI: 10.3892/or-00000891 |
0.656 |
|
2010 |
Co NN, Tsang WP, Tsang TY, Yeung CLA, Yau PL, Kong SK, Kwok TT. AF1q enhancement of γ irradiation-induced apoptosis by up-regulation of BAD expression via NF-κB in human squamous carcinoma A431 cells Oncology Reports. 24: 547-554. DOI: 10.3892/Or_00000891 |
0.449 |
|
2010 |
Yeung CLA, Tsang TY, Co NN, Yau PL, Kwok TT. Abstract 199: HPV-16 E6 silencing of p16INK4a in human cervical cancer cells Cancer Research. 70: 199-199. DOI: 10.1158/1538-7445.Am10-199 |
0.481 |
|
2010 |
Yau PL, Tsang TY, Co NN, Choi SC, Yeung CLA, Kwok TT. Abstract 1045: Enhancement of drug-induced apoptotic cell death in human hepatocellular carcinoma cells with knock-down of BNIP3 Cancer Research. 70: 1045-1045. DOI: 10.1158/1538-7445.Am10-1045 |
0.478 |
|
2009 |
Tsang TY, Tsang SW, Lai KP, Tsang WP, Co NN, Kwok TT. Facilitation of drug resistance development by gamma-irradiation in human cancer cells. Oncology Reports. 22: 921-6. PMID 19724874 DOI: 10.3892/Or_00000518 |
0.655 |
|
2009 |
Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 24: 253-62. PMID 19710540 DOI: 10.1159/000233250 |
0.734 |
|
2008 |
Co NN, Tsang WP, Wong TW, Cheung HH, Tsang TY, Kong SK, Kwok TT. Oncogene AF1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway. Molecular Cancer Therapeutics. 7: 3160-8. PMID 18852119 DOI: 10.1158/1535-7163.Mct-08-0416 |
0.706 |
|
2008 |
Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells. Apoptosis : An International Journal On Programmed Cell Death. 13: 1135-47. PMID 18651222 DOI: 10.1007/S10495-008-0241-6 |
0.745 |
|
2008 |
Co N, Tsang W, Wong T, Tsang T, Kwok T. 491 POSTER AF1q enhancement of doxorubicin induced apoptosis in human squamous carcinoma A431 cells European Journal of Cancer Supplements. 6: 156. DOI: 10.1016/S1359-6349(08)72425-X |
0.66 |
|
2007 |
Wong RP, Tsang WP, Chau PY, Co NN, Tsang TY, Kwok TT. p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3. Molecular Cancer Therapeutics. 6: 1054-61. PMID 17363498 DOI: 10.1158/1535-7163.Mct-06-0336 |
0.673 |
|
Show low-probability matches. |